- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-02-0080041

Brainstem Pharmaceuticals (OPC) Private Limited
About Brainstem Pharmaceuticals (OPC) Private Limited
Data last updated:
Brainstem Pharmaceuticals (OPC) Private Limited is a one person company based in Medchal, Telangana, India. It operates in the social services and community development segment of the non-profit sector. It was incorporated on 10 October 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U85320TG2019OPC135982. Its GSTIN is 36AAICB6845K1Z8 (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by director Yaswin Solanky.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2025. The registered office is at #14/91 Sri Lakshmi Nilayam 5th Line Vrr Enclave Dammaiguda, Medchal, Telangana, India – 500083.
As per the financials filed for FY 2025, the company reported a revenue of ₹97.06 Lakh, a growth of 44% compared to the previous year. For the same year it recorded a net profit of ₹2.72 Lakh (net margin 2.8%) and EBITDA of ₹2.72 Lakh (EBITDA margin 2.8%). Revenue has grown at a compounded annual rate (CAGR) of 30% over three years and 67% over five years.
Brainstem Pharmaceuticals (OPC) Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0080041).
Recognitions & Rankings of Brainstem Pharmaceuticals
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address#14/91 Sri Lakshmi Nilayam 5th Line Vrr Enclave Dammaiguda, Medchal, Telangana, India – 500083
- IndustryNon-Profit Organizations, Social Work, Social Work Activities Without Accommodation
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Brainstem Pharmaceuticals (OPC) Private Limited
The main business activity of Brainstem Pharmaceuticals is support service to organizations. In detail, this covers other support services to organizations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| N | Support service to Organizations | N7 | Other support services to organizations | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Brainstem Pharmaceuticals (OPC) Private Limited FY 2025 filings available
Brainstem Pharmaceuticals (OPC) Private Limited reported revenue of ₹97.06 Lakh (up 44% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Brainstem Pharmaceuticals (OPC) Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 67% over five years, including 44% growth in the latest year. EBITDA rose 215% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Brainstem Pharmaceuticals (OPC) Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.72 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2.72 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Brainstem Pharmaceuticals (OPC) Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Brainstem Pharmaceuticals are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Brainstem Pharmaceuticals (OPC) Private Limited
Brainstem Pharmaceuticals has 1 director on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Yaswin Solanky | Director | 10 Oct 2019 | 7 Years 0 Months | Current |
Peer Comparison of Brainstem Pharmaceuticals (OPC) Private Limited
Brainstem Pharmaceuticals (OPC) Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Forecare Pharmaceuticals Private Limited | ₹97.8 Lakh (FY 2018) | •••• | •••• | 46.0% | •••• | Chennai, Tamil Nadu, India |
| Shenrio Pharmaceuticals India Private Limited | ₹97.69 Lakh (FY 2024) | •••• | •••• | 8.0% | •••• | New Delhi, Delhi, India |
| Medflux Pharmaceuticals Private Limited | ₹97.62 Lakh (FY 2025) | •••• | •••• | -10.0% | •••• | Noida, Uttar Pradesh, India |
| Hermadis Pharmaceuticals Private Limited | ₹97.59 Lakh (FY 2023) | •••• | •••• | -79.0% | •••• | Chennai, Tamil Nadu, India |
| Biocordis Pharmaceuticals Private Limited | ₹97.53 Lakh (FY 2025) | •••• | •••• | 3.0% | •••• | Chandigarh, India |
| Brainstem Pharmaceuticals (OPC) Private Limited this company | ₹97.06 Lakh (FY 2025) | •••• | •••• | 44.0% | •••• | Medchal, Telangana, India |
| Nuthelia Pharmaceuticals Private Limited | ₹96.95 Lakh (FY 2025) | •••• | •••• | 16.0% | •••• | Delhi, India |
| Doqtec Pharmaceuticals Private Limited | ₹96.83 Lakh (FY 2025) | •••• | •••• | 37.0% | •••• | Bhiwani, Haryana, India |
| SNG Pharmaceuticals Private Limited | ₹96.57 Lakh (FY 2025) | •••• | •••• | 10.0% | •••• | Mumbai, Maharashtra, India |
| RML Pharmaceuticals Private Limited | ₹96.47 Lakh (FY 2016) | •••• | •••• | 1186.0% | •••• | New Delhi, Delhi, India |
| Medrica Pharmaceuticals Private Limited | ₹96.26 Lakh (FY 2025) | •••• | •••• | -6.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Brainstem Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Brainstem Pharmaceuticals (OPC) Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Brainstem Pharmaceuticals (OPC) Private Limited
Brainstem Pharmaceuticals (OPC) Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Brainstem Pharmaceuticals (OPC) Private Limited
Employment history and EPFO contributions of people linked to Brainstem Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Brainstem Pharmaceuticals (OPC) Private Limited
Brainstem Pharmaceuticals (OPC) Private Limited has 1 board change on record since 2019: 1 appointment. The latest: Yaswin Solanky was appointed as Director on 10 Oct 2019.
Credit Ratings, Litigation & Regulatory Alerts for Brainstem Pharmaceuticals (OPC) Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Brainstem Pharmaceuticals (OPC) Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Brainstem Pharmaceuticals (OPC) Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Brainstem Pharmaceuticals (OPC) Private Limited
Brainstem Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAICB6845K1Z8 | Telangana | Active | 18 Oct 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Brainstem Pharmaceuticals (OPC) Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Brainstem Pharmaceuticals (OPC) Private Limited
Brainstem Pharmaceuticals is an active company based in Medchal, Telangana, India. The company works in social work, within the non-profit organizations industry. It was incorporated on 10 October 2019 (7+ years old) and is registered under CIN U85320TG2019OPC135982.
Brainstem Pharmaceuticals reported revenue of ₹97.06 Lakh for FY 2025 (up 44% YoY).
Brainstem Pharmaceuticals has 1 current director:
- Yaswin Solanky - Director
Brainstem Pharmaceuticals reported a net profit of ₹2.72 Lakh (net margin 2.8%) and EBITDA of ₹2.72 Lakh (EBITDA margin 2.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Brainstem Pharmaceuticals is 30% over three years and 67% over five years. In the latest year (FY 2025) revenue rose 44%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Brainstem Pharmaceuticals is 36AAICB6845K1Z8, registered in Telangana.
The CIN (Corporate Identification Number) of Brainstem Pharmaceuticals is U85320TG2019OPC135982. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Brainstem Pharmaceuticals was incorporated on 10 October 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Brainstem Pharmaceuticals by revenue are Forecare Pharmaceuticals Private Limited, Shenrio Pharmaceuticals India Private Limited, Medflux Pharmaceuticals Private Limited, Hermadis Pharmaceuticals Private Limited, Biocordis Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Yaswin Solanky was appointed as Director on 10 Oct 2019.
Yes, Brainstem Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0080041).